TITLE

Action Needed to Improve Timeliness and Enhance Scope of FDA's Debarment and Disqualification Processes for Medical Product Investigators

AUTHOR(S)
Crosse, Marcia
PUB. DATE
October 2009
SOURCE
GAO Reports;10/22/2009, preceding p1
SOURCE TYPE
Government Documents
DOC. TYPE
Article
ABSTRACT
The article reports on the study conducted by the U.S. Government Accountability Office (GAO) on the action needed to improve the Food and Drug Administration's (FDA) timely completion of debarment and disqualification processes clinical investigators. It states that investigators who have engaged in wrongful conduct such as presenting fraudulent data can be debarred or disqualified. GAO recommends that the FDA commissioner should ensure the timely completion of the proceedings.
ACCESSION #
45033197

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics